Monday, August 15, 2016 5:57:45 PM
In the CC, management explained that those deaths in low dose arm would have counted as failures but it still has stat sig. The patients on low dose
are sicker than the patients on high dose which are in better shape thus
they could tolerate high dose.
That is why more patients in low dose died (10) vs patients in high dose (2).
This is a small position for me so I bought some more (not recommended for
others).
I believe that the drug does work and the trial is still continuing.
Today is just top line result and they have better analysis by year end.
We will see if I am throwing good money after bad or the gambit works
are sicker than the patients on high dose which are in better shape thus
they could tolerate high dose.
That is why more patients in low dose died (10) vs patients in high dose (2).
This is a small position for me so I bought some more (not recommended for
others).
I believe that the drug does work and the trial is still continuing.
Today is just top line result and they have better analysis by year end.
We will see if I am throwing good money after bad or the gambit works
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
